首页> 外文期刊>International journal of applied mechanics >Lactobacillus Acidophilus/Bifidobacterium Infantis Probiotics Are Beneficial to Extremely Low Gestational Age Infants Fed Human Milk
【24h】

Lactobacillus Acidophilus/Bifidobacterium Infantis Probiotics Are Beneficial to Extremely Low Gestational Age Infants Fed Human Milk

机译:乳杆菌嗜酸性嗜睡症/双歧杆菌益生菌有利于极低的孕龄婴儿喂养人牛奶

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To evaluate the nutrition-related effects of prophylactic Lactobacillus acidophilus/Bifidobacterium infantis probiotics on the outcomes of preterm infants <29 weeks of gestation that receive human milk and/or formula nutrition. We hypothesize that human-milk-fed infants benefit from probiotics in terms of sepsis prevention and growth. Methods: We performed an observational study of the German Neonatal Network (GNN) over a period of six years, between 1 January, 2013 and 31 December, 2018. Prophylactic probiotic use of L. acidophilus/B. infantis was evaluated in preterm infants <29 weeks of gestation (n = 7516) in subgroups stratified to feeding type: (I) Exclusively human milk (HM) of own mother and/or donors (HM group, n = 1568), (II) HM of own mother and/or donor and formula (Mix group, n = 5221), and (III) exclusive exposure to formula (F group, n = 727). The effect of probiotics on general outcomes and growth was tested in univariate models and adjusted in linear/logistic regression models. Results: 5954 (76.5%) infants received L. acidophilus/B. infantis prophylactically for the prevention of necrotizing enterocolitis (NEC). Probiotic use was associated with improved growth measures in the HM group (e.g., weight gain velocity in g/day: effect size B = 0.224; 95% CI: 2.82-4.35; p < 0.001) but not in the F group (effect size B = -0.06; 95% CI: -3.05-0.28; p = 0.103). The HM group had the lowest incidence of clinical sepsis (34.0%) as compared to the Mix group (35.5%) and the F group (40.0%). Only in the Mix group, probiotic supplementation proved to be protective against clinical sepsis (OR 0.69; 95% CI: 0.59-0.79; p < 0.001). Conclusion: Our observational data indicate that the exposure to L. acidophilus/B. infantis probiotics may promote growth in exclusively HM-fed infants as compared to formula-fed infants. To exert a sepsis-preventive effect, probiotics seem to require human milk.
机译:目的:评价预防性乳杆菌嗜酸乳杆菌/双歧杆菌益生菌对早产儿的结果的营养相关效应<收到人乳和/或配方营养的29周的妊娠29周。我们假设人乳喂养的婴儿在脓毒症预防和生长方面受益于益生菌。方法:我们在2013年1月1日至12月3日期间,在六年和2018年12月31日之间进行了对德国新生儿网络(GNN)的观察研究。预防性益生菌使用L. acidophilus / b。在分层为饲喂型的亚组的早产儿(n = 7516)的早产儿(n = 7516)中评估了婴儿:(i)自身母亲和/或供体(HM组,N = 1568)的人牛奶(HM)(II) )自身母亲和/或供体和配方(混合组,N = 5221)的HM,(III)对式(F组,N = 727)不同。益生菌对一般结果和生长的影响在单变量模型中进行了测试,并在线性/逻辑回归模型进行调整。结果:5954(76.5%)婴儿收到L.嗜酸乳杆菌/湾。预防性地预防坏死性小肠结肠炎(NEC)的Infantiis。益生菌使用与HM组中的改善的生长措施有关(例如,G /日中的重量增益速度:效果大小B = 0.224; 95%CI:2.82-4.35; p <0.001)但不在f组中(效果大小B = -0.06; 95%CI:-3.05-0.28; p = 0.103)。与混合物组(35.5%)和F组(40.0%)相比,HM组具有最低的临床脓毒症(34.0%)的发病率最低(34.0%)。只有在混合组中,益生菌补充证明对临床脓毒症(或0.69; 95%CI:0.59-0.79; P <0.001)进行保护。结论:我们的观察数据表明暴露于L. acidophilus / b。与配方喂养婴儿相比,婴儿益生菌可能促进完全HM喂养的婴儿的生长。为了发挥脓毒症预防效果,益生菌似乎需要人乳。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号